Skip to main content
Premium Trial:

Request an Annual Quote

Lumiere to Market Cerno's Mass Spec Software in China

NEW YORK (GenomeWeb News) - Cerno Bioscience said today that it has signed an agreement with Lumiere Technology, under which Lumiere will distribute Cerno’s software in China.
 
Cerno, a developer of mass spectrometry analysis software based in Danbury, Conn., said its MassWorks software can “dramatically improve the amount of information obtainable from and reduce the amount of time required of many MS experiments.”
 
Cerno said the agreement with the Beijing-based Lumiere will exploit the increasing demand for mass spec products in China’s biopharmaceutical and environmental industries.
 
Financial terms of the agreement were not released.
 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more